Wang L, Wang Y, Wang F, Gao Y, Fang Z, Gong W
JMIR Public Health Surveill. 2023; 9:e43586.
PMID: 36917151
PMC: 10131892.
DOI: 10.2196/43586.
Sapuppo G, Tavarelli M, Pellegriti G
Ann Transl Med. 2020; 8(13):838.
PMID: 32793683
PMC: 7396237.
DOI: 10.21037/atm.2020.03.80.
Singh J, Sohal S, Lim A, Duncan H, Thachil T, De Ieso P
Ann Transl Med. 2019; 7(11):245.
PMID: 31317015
PMC: 6603343.
DOI: 10.21037/atm.2019.05.31.
Cao Y, Yue Y, Zhou X, Luo J, Zeng X, Dong J
Medicine (Baltimore). 2019; 98(9):e14654.
PMID: 30817587
PMC: 6831174.
DOI: 10.1097/MD.0000000000014654.
Bai Y, Xu Y, Wu B
Gastroenterol Res Pract. 2018; 2017:2816737.
PMID: 29317864
PMC: 5727640.
DOI: 10.1155/2017/2816737.
Associations between epidermal growth factor receptor mutations and histological subtypes of lung adenocarcinoma according to the IASLC/ATS/ERS classification in Chinese patients.
Wang T, Zhang Y, Liu B, Hu M, Zhou N, Zhi X
Thorac Cancer. 2017; 8(6):600-605.
PMID: 28940943
PMC: 5668489.
DOI: 10.1111/1759-7714.12489.
Latero-cervical lymph node metastases (N1b) represent an additional risk factor for papillary thyroid cancer outcome.
Sapuppo G, Palermo F, Russo M, Tavarelli M, Masucci R, Squatrito S
J Endocrinol Invest. 2017; 40(12):1355-1363.
PMID: 28646475
DOI: 10.1007/s40618-017-0714-y.
Comparative study of Her-2, p53, Ki-67 expression and clinicopathological characteristics of breast cancer in a cohort of northern China female patients.
Ding L, Zhang Z, Xu Y, Zhang Y
Bioengineered. 2017; 8(4):383-392.
PMID: 28075663
PMC: 5553327.
DOI: 10.1080/21655979.2016.1235101.
Differences in quality of life between American and Chinese breast cancer survivors.
Lu Q, You J, Kavanagh A, Warmoth K, Meng Z, Chen Z
Support Care Cancer. 2016; 24(9):3775-82.
PMID: 27048455
PMC: 5421630.
DOI: 10.1007/s00520-016-3195-1.
Radiation-induced brachial plexopathy in patients with nasopharyngeal carcinoma: a retrospective study.
Cai Z, Li Y, Hu Z, Fu R, Rong X, Wu R
Oncotarget. 2016; 7(14):18887-95.
PMID: 26934119
PMC: 4951337.
DOI: 10.18632/oncotarget.7748.
Plasma Epstein-Barr viral DNA complements TNM classification of nasopharyngeal carcinoma in the era of intensity-modulated radiotherapy.
Zhang L, Tang L, Chen Q, Liu H, Guo S, Liu L
Oncotarget. 2015; 7(5):6221-30.
PMID: 26716900
PMC: 4868751.
DOI: 10.18632/oncotarget.6754.
Impact of the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification of stage IA adenocarcinoma of the lung: Correlation between computed tomography images and EGFR and KRAS gene....
Wang T, Zhang T, Han X, Liu X, Zhou N, Liu Y
Exp Ther Med. 2015; 9(6):2095-2103.
PMID: 26136941
PMC: 4473664.
DOI: 10.3892/etm.2015.2422.
Determinants of gastric cancer screening attendance in Korea: a multi-level analysis.
Chang Y, Cho B, Son K, Shin D, Shin H, Yang H
BMC Cancer. 2015; 15:336.
PMID: 25927821
PMC: 4424570.
DOI: 10.1186/s12885-015-1328-4.
Brentuximab vedotin for relapsed or refractory CD30+ Hodgkin lymphoma: a multicenter analysis from Asia.
Yang Q, Hong J, Ko Y, Lin S, Au W, Choi M
Onco Targets Ther. 2014; 7:1717-22.
PMID: 25328405
PMC: 4196794.
DOI: 10.2147/OTT.S67380.
Cancer control programs in East Asia: evidence from the international literature.
Moore M
J Prev Med Public Health. 2014; 47(4):183-200.
PMID: 25139165
PMC: 4162122.
DOI: 10.3961/jpmph.2014.47.4.183.
Birthplace is not a determinant of colorectal adenomas.
Tran F, Koo J
World J Gastroenterol. 2014; 20(26):8606-11.
PMID: 25024615
PMC: 4093710.
DOI: 10.3748/wjg.v20.i26.8606.
Prostate cancer in Asian men.
Ito K
Nat Rev Urol. 2014; 11(4):197-212.
PMID: 24595118
DOI: 10.1038/nrurol.2014.42.
Estrogen receptor alpha gene polymorphisms and risk of prostate cancer: a meta-analysis involving 18 studies.
Gu Z, Wang G, Chen W
Tumour Biol. 2014; 35(6):5921-30.
PMID: 24584714
DOI: 10.1007/s13277-014-1785-4.
Can Western based online prostate cancer risk calculators be used to predict prostate cancer after prostate biopsy for the Korean population?.
Lee D, Jung H, Won Park J, Kim K, Kim J, Lee S
Yonsei Med J. 2013; 54(3):665-71.
PMID: 23549812
PMC: 3635620.
DOI: 10.3349/ymj.2013.54.3.665.
Gene-guided gefitinib switch maintenance therapy for patients with advanced EGFR mutation-positive non-small cell lung cancer: an economic analysis.
Zhu J, Li T, Wang X, Ye M, Cai J, Xu Y
BMC Cancer. 2013; 13:39.
PMID: 23360224
PMC: 3568065.
DOI: 10.1186/1471-2407-13-39.